Kalabay et al. investigated the prevalence of anti-HP antibodies in a variety of autoimmune rheumatic diseases and revealed HP prevalence to be comparable in patients with SLE and healthy controls (25). This evidence concerns the gene HP and systemic lupus erythematosus.